Spironolactone Tablet, Film Coated
Product Images NDC 72162-2150

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72162-2150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Spironolactone Structural Formula (Image 01)

Spironolactone Structural Formula (Image 01)
FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Image 02)

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Image 02)
This text appears to be a comparison of Spironolactone and Placebo in a study. The study includes a total of 822 participants who received Spironolactone and 841 participants who received Placebo. The text mentions a Log - rank p value of < 0.001, indicating a statistically significant result. The timeframe mentioned is in months, starting from 6 months and going up to 48 months.*
FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Image 03)

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Image 03)
FDA Label Image

Label (Lbl721622150)

Label (Lbl721622150)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.